Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antimuscarinic agent |
| gptkbp:ATCCode |
gptkb:A03AB12
|
| gptkbp:CASNumber |
gptkb:62-13-5
|
| gptkbp:eliminationHalfLife |
1.8 hours
|
| gptkbp:hasMolecularFormula |
gptkb:C21H26NO3
|
| https://www.w3.org/2000/01/rdf-schema#label |
mepenzolate
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
muscarinic acetylcholine receptor antagonist
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:PubChem_CID |
gptkb:DB00943
4057 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
blurred vision dry mouth urinary retention |
| gptkbp:synonym |
gptkb:mepenzolate_bromide
|
| gptkbp:UNII |
6O474A40B6
|
| gptkbp:usedFor |
gptkb:peptic_ulcer_disease
|
| gptkbp:bfsParent |
gptkb:Cantil
|
| gptkbp:bfsLayer |
7
|